What Is Selank? Anxiolytic-Class Peptide Research

Searching "what is Selank"? Selank is a synthetic heptapeptide developed from tuftsin, a naturally occurring immunomodulatory tetrapeptide. It is studied in the anxiolytic-class research literature and is supplied strictly as a research-grade reference standard for in-vitro laboratory research. This overview summarizes what the research describes — its tuftsin origin, the models it appears in, and how it contrasts with Semax — not any application.

What is Selank?

Selank is built on the tuftsin sequence (Thr-Lys-Pro-Arg) extended with a Pro-Gly-Pro stabilizing tail, giving the heptapeptide Thr-Lys-Pro-Arg-Pro-Gly-Pro. The tuftsin core links it to immune-signaling research, while the added prolines make it more resistant to enzymatic degradation than bare tuftsin — which is why Selank is studied as a comparatively stable peptide in degradation assays. Like Semax, it was developed at Russian research institutes, and much of its foundational literature comes from that tradition.

The tuftsin connection

Tuftsin itself is a fragment of the immunoglobulin heavy chain with documented immunomodulatory activity in research models. Selank inherits that lineage, which is why parts of the Selank literature examine immune-signaling endpoints alongside the more prominent anxiolytic-class threads. This dual heritage — an immune-active core repurposed into a CNS-research probe — is part of what makes Selank distinctive among short neuropeptides.

Structure and stability

The Pro-Gly-Pro tail is the same stabilization strategy used in Semax: proline residues resist many peptidases, extending the peptide's functional half-life in degradation assays relative to bare tuftsin. This makes Selank a more durable probe for the pathways it's studied in, and it's a recurring design feature across the Russian neuropeptide family.

What is Selank studied for in research models?

The Selank literature clusters around a few research themes.

• GABAergic-signaling models — investigations of GABA-pathway modulation in animal and in-vitro systems.
• Enkephalin-degradation research — Selank has been studied for its reported influence on the enzyme that breaks down enkephalins, affecting endogenous peptide levels in research models.
• Anxiolytic-class behavioral models — animal-model studies characterizing anxiety-related endpoints.
• Immunomodulation assays — reflecting the tuftsin origin, work on cytokine and immune-signaling readouts.
• Neurotransmitter-balance research — exploratory studies of monoamine and inhibitory-signaling endpoints.

These describe what Selank has been investigated for in controlled research settings. They are not claims of any effect in humans. The recurring anxiolytic-class framing reflects the behavioral models the peptide appears in — not any anxiety-related outcome in people, which is outside the scope of research-use material.

How does Selank compare to Semax?

Selank is frequently paired with Semax because both are short, stability-engineered peptides studied in neuro research. The key contrast: Selank traces to tuftsin and is studied in anxiolytic-class and GABAergic models, while Semax traces to ACTH(4-10) and is studied in neurotrophic and neuroprotection models. They share a proline-tail stabilization design but probe different pathways — inhibitory-neurotransmitter and immune signaling for Selank, growth-factor signaling for Semax. The full breakdown lives in our Semax vs Selank comparison.

Why is Selank described as anxiolytic-class?

The "anxiolytic-class" label attached to Selank in research discussion reflects the behavioral models it appears in, not any effect in people. In animal-model research, anxiety-related endpoints are studied using standardized paradigms, and compounds examined against those paradigms are grouped into the anxiolytic-class research category. Selank's appearance there — together with its study in GABAergic and enkephalin-degradation pathways, both mechanistically relevant to that category — is what earns the label.

Reading the label correctly matters for compliance and for accurate research framing: it describes where the peptide is studied, not a claimed outcome. Selank is a reference standard for investigating those pathways in vitro and in animal models, and nothing about the anxiolytic-class designation implies suitability for any human application.

The mechanistic threads behind the label are worth understanding on their own terms. GABA is the principal inhibitory neurotransmitter in the central nervous system, so GABAergic-signaling models are a natural place to study compounds in the anxiolytic-class research category. Separately, the enkephalin-degradation thread is notable because enkephalins are endogenous signaling peptides, and any compound studied for influencing the enzyme that breaks them down is, in effect, being examined for a way to modulate native peptide levels in a research model. Selank's appearance across both threads — plus its tuftsin-derived immune endpoints — is what gives it a multi-pathway research profile rather than a single clean mechanism.

How is Selank handled in the lab?

Selank is supplied lyophilized and reconstituted with a diluent such as bacteriostatic water before assay use. The reconstitution calculator returns working concentrations and aliquot volumes for any vial size. Lyophilized peptides ship and store well, but the made-up solution should be handled gently and kept cold to preserve integrity. Every Eon Research lot is supplied lyophilized in multi-vial research kits that ship from our US facility within 48 hours with tracking. Selank sits within our cognitive and neuro catalog.